Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 15245535)

Published in Clin Exp Dermatol on July 01, 2004

Authors

M B Abdel Naser1, U Wollina, M El Okby, S El Shiemy

Author Affiliations

1: Department of Dermatology, Ain Shams University, Cairo, Egypt. abdelnasermb@yahoo.com

Articles by these authors

Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase. Arch Dermatol (2000) 2.72

Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43

The relationship of epidermal hyperplasia and Merkel cell hyperplasia. Dermatologica (1990) 1.40

Muir-Torre syndrome - treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology (2000) 1.01

Mineral oil granuloma of the penis. J Eur Acad Dermatol Venereol (2003) 1.01

Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol (1997) 1.00

Intracutaneous botulinum toxin A versus ablative therapy of Hailey-Hailey disease--a case report. J Cosmet Laser Ther (2001) 1.00

Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol (2014) 0.99

Cetirizine-induced urticarial reaction. Br J Dermatol (1999) 0.98

Photobiology of lupus erythematosus. Arch Dermatol Res (1990) 0.96

Otosyphilis: report on six cases. J Eur Acad Dermatol Venereol (2004) 0.94

Painful ulcers in calciphylaxis - combined treatment with maggot therapy and oral pentoxyfillin. J Dermatolog Treat (2001) 0.94

A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix. Hum Genet (1997) 0.93

Disseminated bullous eruption with systemic reaction caused by Cimex lectularius. J Eur Acad Dermatol Venereol (2003) 0.93

Epidermal calmodulin levels in psoriasis. J Invest Dermatol (1987) 0.93

Sarcoidosis, cancer and molecular mimicry. Int J Immunopathol Pharmacol (2013) 0.93

Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony). A single-centre analysis of 1881 patients with a follow-up of 10 years or more. J Eur Acad Dermatol Venereol (2010) 0.92

Efficacy and tolerability of an ulcer compression stocking for therapy of chronic venous ulcer compared with a below-knee compression bandage: results from a prospective, randomized, multicentre trial. Curr Med Res Opin (2004) 0.91

Ulcerative lichen planus: a case responding to recombinant platelet-derived growth factor BB and immunosuppression. Acta Derm Venereol (2002) 0.90

Second malignancies in melanoma patients in Thuringia. J Eur Acad Dermatol Venereol (2000) 0.90

Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. J Invest Dermatol (1997) 0.89

Cutaneous angiosarcoma of the face: clinicopathologic and immunohistochemical study of a case resembling rosacea clinically. J Am Acad Dermatol (1998) 0.89

Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am J Ther (1998) 0.88

Expression of TGF-beta related Smad proteins in human epithelial skin tumors. Int J Oncol (1999) 0.87

Extracorporeal photochemotherapy in nodular scleroderma. Br J Dermatol (1998) 0.86

Bilateral callosities, plantar ulcers and peripheral neuropathy in a 15-year-old nondiabetic boy--think of neuroborreliosis. J Eur Acad Dermatol Venereol (2005) 0.85

Disabling morphoea of childhood-beneficial effect of intravenous immunoglobulin therapy. Clin Exp Dermatol (1998) 0.84

Pansclerotic morphea of childhood-follow-up over 6 years. Pediatr Dermatol (1999) 0.84

Unilateral hyperhidrosis, callosities, and nail dystrophy in a boy with tethered spinal cord syndrome. Pediatr Dermatol (1999) 0.83

Acute generalized exanthematous pustulosis (AGEP): manifestation of drug allergy to propicillin. Contact Dermatitis (1995) 0.83

Therapeutic ultrasound for pressure ulcers. Cochrane Database Syst Rev (2006) 0.83

Generation of reactive oxygen species by Candida albicans in relation to morphogenesis. Arch Dermatol Res (2000) 0.83

Genital ulcers in a psoriasis patient using topical tazarotene. Br J Dermatol (1998) 0.82

[Epidermal lectin binding in psoriasis vulgaris. III. Galactosamine and glucosamine glycoconjugates]. Dermatol Monatsschr (1988) 0.82

Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol (2006) 0.82

Polydactylous Bowen's disease. J Eur Acad Dermatol Venereol (2003) 0.81

Merkel cell carcinoma--a retrospective analysis of 17 cases. J Eur Acad Dermatol Venereol (2003) 0.81

Inhibitory effect of terbinafine on reactive oxygen species (ROS) generation by Candida albicans. Mycoses (2002) 0.81

[Argon laser therapy of multiple eccrine cysts of sweat gland efferent ducts (eccrine hidrocystomas)]. Klin Monbl Augenheilkd (1996) 0.81

The response of erythematous rosacea to ondansetron. Br J Dermatol (1999) 0.80

Non-sarcoidal, non-tuberculoid granuloma in common variable immunodeficiency. J Drugs Dermatol (2006) 0.80

Contact-free spectroscopy of leg ulcers: principle, technique, and calculation of spectroscopic wound scores. J Invest Dermatol (2001) 0.80

Botulinum A toxin for wrinkles: release from tension headache. J Eur Acad Dermatol Venereol (2000) 0.80

Acute paronychia: comparative treatment with topical antibiotic alone or in combination with corticosteroid. J Eur Acad Dermatol Venereol (2001) 0.79

Gentamicin-induced anaphylaxis. Allergy (2003) 0.79

[Antibodies to double-stranded DNA in psoriasis?]. Dermatol Monatsschr (1984) 0.79

[Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. II. Antibodies against histone, Sm, Ro and La]. Allerg Immunol (Leipz) (1983) 0.79

[Cutaneous side-effects of nonsteroidal anti-inflammatory drugs (NSAID)]. Z Rheumatol (1996) 0.79

Acquired clubbing of the great toenail. Digital mucoid cyst (pseudocyst). Arch Dermatol (1996) 0.79

Botulinum toxin A for focal hyperhidrosis in leg amputees: a case report. Acta Derm Venereol (2000) 0.79

Monilethrix--improvement by hormonal influences? Pediatr Dermatol (1999) 0.79

[CRST syndrome with stigmata of mixed connective tissue disease. Case contribution to overlap symptoms]. Dermatol Monatsschr (1984) 0.78

Immune complexes--pathogenetic factors of autoimmune systemic lupus erythematosus. Allerg Immunol (Leipz) (1984) 0.78

[Monosymptomatic Melkersson-Rosenthal syndrome with subsequent vulvitis and perivulvitis granulomatosa]. Hautarzt (1992) 0.78

Analysis of the tumor suppressor gene p16(INK4A) in microdissected melanoma metastases by sequencing, and microsatellite and methylation screening. Arch Dermatol Res (1999) 0.78

Interferon for tufted angioma. Pediatr Dermatol (1999) 0.78

Linguistic validation of the Cardiff Wound Impact Schedule into French, German and US English. J Wound Care (2005) 0.78

[Leg swelling]. Internist (Berl) (2013) 0.78

[X-ray irradiation of the human epidermis in vitro. II. Comparison of a single 44 kV and 200 kV x-ray irradiation]. Radiobiol Radiother (Berl) (1989) 0.78

[Orienting studies on the direct effect of various radiation types and energies on lectin binding of the human epidermis in vitro]. Radiobiol Radiother (Berl) (1988) 0.78

Pansclerotic morphea in childhood: a case report. Pediatr Surg Int (2003) 0.77

Targeted 307 nm UVB-excimer light vs. topical dithranol in psoriasis. J Eur Acad Dermatol Venereol (2011) 0.77

Postvaccination inflammatory papules of the skin--think of Bacille Calmette-Guérin (BCG) Pediatr Dermatol (1998) 0.77

Tufted angioma. Eur J Dermatol (1999) 0.77

The prevention of occupational hand dermatitis in bakers, confectioners and employees in the catering trades. Preliminary results of a skin prevention program. Contact Dermatitis (2001) 0.77

[The keratinocyte--a biologically active cell]. Dermatol Monatsschr (1990) 0.77

Oral disease caused by the chewing of betel nut and concoctions containing betel nut. J Eur Acad Dermatol Venereol (2004) 0.77

Autocrine endothelial regulation in brain stem vessels of newborn piglets. Histol Histopathol (1999) 0.77

Psoriasis and Brooke-Spiegler syndrome with multiple malignancies. J Eur Acad Dermatol Venereol (2005) 0.77

Long-term cyclosporin A in systemic sclerosis. J Eur Acad Dermatol Venereol (2004) 0.76

Reactive oxygen species in human semen: investigations and measurements. Arch Androl (1998) 0.76

[Late manifestation of a fatal Behçet's disease with cardiac involvement and lethal outcome]. Dtsch Med Wochenschr (1998) 0.76

Denture-induced local and systemic reactions to acrylate. Allergy (1998) 0.76

Successful ultraviolet A1 treatment of cutaneous sarcoidosis. Br J Dermatol (2001) 0.76

[Immunohistochemical detection of calmodulin. A contribution to the histogenetic classification of eccrine poroma and clear cell acanthoma]. Dermatol Monatsschr (1990) 0.76

Current epidemiological data from the German Registry of Adamantiades-Behçet's disease. Adv Exp Med Biol (2003) 0.75

PUVA treatment of human cultured fibroblasts from psoriatic skin enhances the binding of antibodies to SSA(Ro). Arch Dermatol Res (1987) 0.75

Angiosarcoma of the scalp: new treatment modalities. J Eur Acad Dermatol Venereol (2001) 0.75

Calmodulin in human skin--localizations and interpretations. Arch Dermatol Res (1993) 0.75

Juvenile generalized pustular psoriasis. Acta Derm Venereol (1998) 0.75

[Reader's letter on Marcus Meissner, Jens, Gille, Roland Kaufmann. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?]. J Dtsch Dermatol Ges (2007) 0.75

Somatostatin and psoriasis. Acta Derm Venereol (1998) 0.75

Treatment of dystrophic calcification in leg ulcers. Int Wound J (2005) 0.75

Histopathologic features of progression in Mediterranean and immunodeficiency-related Kaposi sarcoma. Am J Dermatopathol (2000) 0.75

Increased risk of cancer in patients with scleroderma: no risk in patients with morphoea? Ann Rheum Dis (2004) 0.75

Pulse corticosteroid therapy in juvenile dermatomyositis. Pediatr Dermatol (1997) 0.75

Red lunula in systemic lupus erythematosus. J Am Acad Dermatol (1998) 0.75

Calmodulin and psoriasis. Br J Dermatol (1989) 0.75

Electrophoretic mobilities of keratinocytes from normal skin and psoriatic lesions. Arch Dermatol Res (1992) 0.75

Expression of vimentin in human keratinocytes. Arch Dermatol Res (1997) 0.75

Antibodies to dsDNA in connective tissue diseases measured by ultramicro enzyme-linked immunosorbent assay (ELISA) adapted to the chamber analytical technique (CAT). Arch Dermatol Res (1984) 0.75

Nonlinear behaviour of anti-dsDNA antibodies in dilution experiments using ultramicro ELISA. Arch Dermatol Res (1985) 0.75

[Peripheral T-cell lymphoma: diagnosis and treatment]. Dtsch Med Wochenschr (2006) 0.75

Extracorporeal photopheresis for scleroderma. J Am Acad Dermatol (2001) 0.75

Management of dermato-rheumatic syndromes. Br J Rheumatol (1998) 0.75

Development of occupational skin diseases during vocational training in baker and confectioner apprentices: a follow-up study. Contact Dermatitis (1998) 0.75

Treatment of bullous pemphigoid: what's new? J Eur Acad Dermatol Venereol (2003) 0.75

[Expression of alpha-1-fucose in the glycocalyx of human gingival mucosa and epidermis. A comparative study]. Dtsch Z Mund Kiefer Gesichtschir (1989) 0.75

[Photochemotherapy in vitro--direct effect on epidermal lectin-binding of psoriatic and normal skin]. Dermatol Monatsschr (1988) 0.75